Provided By GlobeNewswire
Last update: Mar 8, 2024
Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy.
NASDAQ:LFWD (8/25/2025, 1:53:13 PM)
0.647
+0.03 (+5.2%)
Find more stocks in the Stock Screener